Full Text
The Full Text of this article is available as a PDF (347.8 KB).
letter . 1997 Sep 13;315(7109):677.
Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Combining thromboembolic events with cardiovascular events does not support odds ratio of 0.7.
T Sundkvist
T Sundkvist
Find articles by T Sundkvist
PMCID: PMC2127472 PMID: 9310578
See the article "Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials." on page 149.